[ExI] statins

William Flynn Wallace foozler83 at gmail.com
Fri Sep 9 18:42:02 UTC 2016

And London cardiologist Dr Assem Malhotra said: "There are serious question
marks about the reliability of industry-sponsored studies on the side
effects of statins, and essentially that's what this review is.

"And a lot of the scientists involved in the original studies were involved
in this review. It is not an independent review."

This is a quote from the BBC article that Bill K sent to me.  It confirms
what I think:  you can't trust industry, which is making billions from the
drugs, to do unquestioned research.

bill w

On Thu, Sep 8, 2016 at 6:14 PM, BillK <pharos at gmail.com> wrote:

> On 7 September 2016 at 15:54, William Flynn Wallace  wrote:
> > The problem withe both of these criticisms is that you are relying on
> > government and top medical sources, which are politically compromised.
> Just
> > look into the American Heart Association and its history of supporting
> > questionable data about fats, which is just now being overturned.  "Use
> only
> > polyunsaturated fats."  Problem is, they lower HDL too.
> >
> > People's Pharmacy is not without its problems but at least it's an
> > independent source.  Read everybody, trust no one.
> <snip>
> > Of course I am not qualified to judge primary sources, so I won't waste
> my
> > time.
> >
> You have to rely on some medical sources. Try to choose reliable
> sources. It's your life at stake.
> News just in:
> <http://www.bbc.co.uk/news/health-37306736>
> Quote:
> Statins review says benefits 'underestimated'
> The benefits of the cholesterol-reducing drug statins are
> underestimated and the harms exaggerated, a major review suggests.
> Published in the Lancet and backed by a number of major health
> organisations, it says statins lower heart attack and stroke risk.
> The review also suggests side effects such as muscle pain do occur,
> although in relatively few people.
> The Lancet review, led by Prof Rory Collins from the Clinical Trial
> Service Unit at the University of Oxford, looked at the available
> evidence for the effects of taking an average 40mg daily dose of
> statins in 10,000 patients over five years.
> It suggested cholesterol levels would be lowered enough to prevent
> 1,000 "major cardiovascular events" such as heart attacks, strokes and
> coronary artery bypasses in people who had existing vascular disease -
> and 500 in people who were at risk due to age or other illnesses such
> as high blood pressure or diabetes.
> -------------
> BillK
> _______________________________________________
> extropy-chat mailing list
> extropy-chat at lists.extropy.org
> http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.extropy.org/pipermail/extropy-chat/attachments/20160909/6e0fdc06/attachment.html>

More information about the extropy-chat mailing list